Robert G. Funari, Director at NxStage Medical, Inc. (NXTM), bought 10,150 shares at $14.72 ($149K) on 2014-03-06, disclosed to the SEC on 2014-03-07.
Open-market purchase of $149k NXTM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.